news

BreathForDx Is Now on Bluesky — Join the Conversation!

16 April 2025
We’re excited to announce that BreathForDx is now on Bluesky, a new platform for innovation, collaboration, and global dialogue in science and health.

BreathForDx is an EU-funded initiative focused on transforming the way we diagnose respiratory infections—such as tuberculosis—by using exhaled breath aerosols (XBA) as a novel, non-invasive diagnostic sample. Our goal is to develop portable, accessible, and reliable tools that bring accurate diagnostics closer to patients, especially in resource-limited settings.

Why Follow @breathfordx.bsky.social?

🧬 Innovation in Respiratory Diagnostics
Get the latest updates on our research, technological advances, and project milestones.

🌐 Global Collaboration & Impact
See how BreathForDx is building partnerships and driving change in diagnostics worldwide.

📖 Stories from the Field
Discover how our work is making a difference—from lab discoveries to real-world impact.

👉 Follow us now at: @breathfordx.bsky.social

Let’s breathe new life into diagnostics—together.